Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Line Clearance Before Manufacturing – V 2.0

Posted on By

Elixir Department: SOP for Line Clearance Before Manufacturing – V 2.0

Standard Operating Procedure for Line Clearance Before Manufacturing in Elixir Department

Department Elixir Department
SOP No. SOP/ELX/072/2025
Supersedes SOP/ELX/072/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To outline the procedure for line clearance in the Elixir Department before initiating batch manufacturing, ensuring the area, equipment, and materials are free from any previous batch residues, documents, and unrelated items.

2. Scope

This SOP is applicable to all manufacturing areas and equipment used in the preparation of elixirs, including mixing, transfer, and storage zones, prior to starting a new batch.

3. Responsibilities

  • Production Operator:
    • Perform preliminary checks of cleanliness and remove unrelated items.
  • Production Supervisor:
    • Conduct detailed area inspection and complete line clearance checklist.
  • QA Officer:
    • Verify line clearance, ensure compliance, and authorize start of batch by signing clearance form.
See also  Elixir Department: SOP for Weekly Preventive Cleaning - V 2.0

4. Accountability

The Production Manager is accountable for ensuring that line clearance is properly executed and documented before beginning any batch operation.

5. Procedure

5.1 Prerequisite

  1. Ensure completion of cleaning and
sanitization activities prior to line clearance.
  • Verify that all status labels are updated and area is under “CLEANED” condition.
  • 5.2 Line Clearance Steps

    1. Remove all documents, labels, and product remnants of the previous batch.
    2. Ensure no raw materials, semi-finished products, or containers from previous batches are present.
    3. Check equipment cleanliness and availability of calibrated instruments.
    4. Ensure waste bins are empty and cleaned.
    5. Verify the availability of the correct batch manufacturing record (BMR) and materials for the next batch.

    5.3 Documentation

    1. Complete the Line Clearance Checklist (Annexure-1) for each batch.
    2. Record the name, signature, and date of the production and QA personnel involved in the clearance.
    3. Submit the signed checklist to QA for archival along with BMR.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • QA: Quality Assurance
    • BMR: Batch Manufacturing Record
    • cGMP: Current Good Manufacturing Practice

    7. Documents

    1. Line Clearance Checklist (Annexure-1)
    2. Line Clearance Tag (Annexure-2)
    3. BMR – Line Clearance Section

    8. References

    • 21 CFR Part 211.130 – Packaging and Labeling Control
    • WHO GMP Guidelines – Production Area Requirements

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Line Clearance Checklist

    Checklist Item Status (Yes/No) Remarks
    All equipment cleaned and labeled Yes Verified visually
    Previous batch documents removed Yes Disposed
    Correct BMR present Yes ELX-1015
    Calibration of balances verified Yes Valid till 12/2025

    Annexure-2: Line Clearance Tag

    Area Equipment ID Cleared By Date Status
    Mixing Area MXV-03 Sunita Reddy 11/04/2025 CLEARED

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial Release New SOP QA Head
    11/04/2025 2.0 Added Tag Format and Checklist Fields Process Clarity QA Head
    See also  Elixir Department: SOP for Clarity and Opalescence Testing - V 2.0
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: Gel Manufacturing: SOP for Transferring Gels to Filling Lines – V 2.0
    Next Post: Biosimilars: SOP for Microbial Contamination Check During Culture in Bioreactor Operations – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version